Pharmafile Logo
Pharmafocus logo
Advanced Search

trial analysis

Showing 1 posts of 1 posts found.

AstraZeneca’s AMPLIFY trial interim analysis demonstrates positive results for Calquence plus venetoclax

July 30, 2024
Research and Development AstraZeneca, Haematology, chronic lymphocytic leukaemia, haematology, trial analysis

AstraZeneca has announced positive high-level results from an interim analysis for its AMPLIFY phase 3 trial, combining AstraZeneca’s Calquence (acalabrutinib) …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025